Toxoplasma gondii infection and neuropsychiatric disease: current insight

References

• Miman O, Kusbeci OY, Aktepe OC, Cetinkaya Z. The probable relation between Toxoplasma gondii and Parkinson’s disease. Neurosci Lett. 2010;475(3):129–131.
   PubMed Web of Science ®Google Scholar
• Torrey EF, Yolke RH. Toxoplasma gondii and schizophrenia. Emerg Infect Dis. 2003;9(11):1375–1380.
   Web of Science ®Google Scholar
• Hinze-Selch D. Infection, treatment and immune response in patients with bipolar disorder versus patients with major depression, schizophrenia or healthy controls. Bipolar Disord. 2002;4 Suppl 1:81–83.
   Google Scholar
• Delgado-Garcia G, Rodriguez Perdomo E. Reactivity of toxoplasmin intradermal test in neurotic and manic-depressive patients. Rev Cubana Med Trop. 1980;32(1):35–39.
   Google Scholar
• Evans AK, Strassmann PS, Lee IP2, Sapolsky RM. Patterns of Toxoplasma gondii cyst distribution in the forebrain associate with individual variation in predator odor avoidance and anxiety-related behavior in male Long-Evans rats. Brain Behav Immun. 2014;37:122–133.
   PubMed Web of Science ®Google Scholar
• Flegr J, Preiss M, Klose J, Havlícek J, Vitáková M, Kodym P. Decreased level of psychobiological factor novelty seeking and lower intelligence in men latently infected with the protozoan parasite Toxoplasma gondii Dopamine, a missing link between schizophrenia and toxoplasmosis? Biol Psychol. 2003;63(3):253–368.
   Google Scholar
• Torrey EF. Stalking the Schizovirus. Schizophr Bull. 1988;14(2):223–229.
   Web of Science ®Google Scholar
• Torrey EF, Yolken R. Could schizophrenia be a viral zoonosis transmitted from house cats? Schizophr Bull. 1995;21(2):167–171.
   Web of Science ®Google Scholar
• Torrey EF, Miller J, Rawlings R, Yolken RH. Seasonality of births in schizophrenia and bipolar disorder: a review of the literature. Schizophr Res. 1997;28(1):1–38.
   PubMed Web of Science ®Google Scholar
• Torrey EF, Yolken RH. The schizophrenia-rheumatoid arthritis connection: infectious, immune, or both? Brain Behav Immun. 2001;15(4):401–410.
   Web of Science ®Google Scholar
• Camus D, Zalis MG, Vannier-Santos MA, Banic DM. The art of parasite survival. Braz J Med Biol Res. 1995;28(4):399–413.
   Web of Science ®Google Scholar
• Torrey EF, Yolken RH. The urban risk and migration risk factors for schizophrenia: are cats the answer? Schizophr Res. 2014;159(2–3):299–302.
   Web of Science ®Google Scholar
• Parlog A, Harsan LA, Zagrebelsky M, et al. Chronic murine toxoplasmosis is defined by subtle changes in neuronal connectivity. Dis Model Mech. 2014;7(4):459–469.
   PubMed Web of Science ®Google Scholar
• Gatkowska J, Wieczorek M, Dziadek B, Dzitko K, Dlugonska H. Sex-dependent neurotransmitter level changes in brains of Toxoplasma gondii infected mice. Exp Parasitol. 2013;133(1):1–7.
   Web of Science ®Google Scholar
• Strobl JS, Goodwin DG, Rzigalinski BA, Lindsay DS. Dopamine stimulates propagation of Toxoplasma gondii tachyzoites in human fibroblast and primary neonatal rat astrocyte cell cultures. J Parasitol. 2012;98(6):1296–1299.
   PubMed Web of Science ®Google Scholar
• Kusbeci OY, Miman O, Yaman M, Aktepe OC, Yazar S. Could Toxoplasma gondii have any role in Alzheimer disease? Alzheimer Dis Assoc Disord. 2011;25(1):1–3.
   Google Scholar
• Jung BK, Pyo KH, Shin KY, et al. Toxoplasma gondii infection in the brain inhibits neuronal degeneration and learning and memory impairments in a murine model of Alzheimer’s disease. PLoS One. 2012;7(3):e33312.
   PubMed Web of Science ®Google Scholar
• Hinze-Selch D, Däubener W, Eggert L, Erdag S, Stoltenberg R, Wilms S. A controlled prospective study of Toxoplasma gondii infection in individuals with schizophrenia: beyond seroprevalence. Schizophr Bull. 2007;33(3):782–788.
   Web of Science ®Google Scholar
• Celik T, Kamisli O, Babür C, Cevik MO, Oztuna D, Altinayar S. Is there a relationship between Toxoplasma gondii infection and idiopathic Parkinson’s disease? Scand J Infect Dis. 2010;42(8):604–608.
   Google Scholar
• Ngoungou EB, Bhalla D, Nzoghe A, Dardé ML, Preux PM. Toxoplasmosis and epilepsy – systematic review and meta-analysis. PLoS Negl Trop Dis. 2015;9(2):e0003525. doi: 10.1371/journal.pntd.0003525.
   PubMed Web of Science ®Google Scholar
• Pestehchian N, Etemadifarr M, Yousefi HA, Chiani M, Aslani N, Nasr Z. Frequency of blood-tissue parasitic infections in patients with multiple sclerosis, as compared to their family members. Int J Prev Med. 2014;5(12):1578–1581.
   Google Scholar
• Bilgrami M, O’Keefe P. Neurologic diseases in HIV-infected patients. Handb Clin Neurol. 2014;121:1321–1344.
   PubMedGoogle Scholar
• Heitman BB, Irizarry AF. Recognition and management of toxoplasmosis. Nurse Pract. 1997;22(9):75, 79–82, 85–86.
   Google Scholar
• Prandota J. The importance of Toxoplasma gondii infection in diseases presenting with headaches. Headaches and aseptic meningitis may be manifestations of the Jarisch–Herxheimer reaction. Int J Neurosci. 2009;119(12):2144–2182.
   PubMed Web of Science ®Google Scholar
• Delgado García G, García Landa J. Reactivity of the intradermal test with toxoplasmosis in schizophrenic patients. Rev Cubana Med Trop. 1979;31(3):225–231.
   Google Scholar
• Choi WY, Yoo JE, Chung CS, Paik KK, Cho SN. Toxoplasma antibodies by indirect latex agglutination tests in national Seoul mental hospital patients. Kisaengchunghak Chapchi. 1983;21(2):281–285.
   Google Scholar
• Yolken RH, Bachmann S, Ruslanova I, et al. Antibodies to Toxoplasma gondii in individuals with first-episode schizophrenia. Clin Infect Dis. 2001;32(5):842–844.
   Web of Science ®Google Scholar
• Park MH, Kwon YJ, Jeong HY, et al. Association between intracellular infectious agents and schizophrenia. Clin Psychopharmacol Neurosci. 2012;10(2):117–123.
   Google Scholar
• James BO, Agbonile IO, Okolo M, Lawani AO, Omoaregba JO. Prevalence of Toxoplasma gondii infection among individuals with severe mental illness in Nigeria: a case control study. Pathog Glob Health. 2013;107(4):189–193.
   Web of Science ®Google Scholar
• Emelia O, Amal RN, Ruzanna ZZ, et al. Seroprevalence of anti-Toxoplasma gondii IgG antibody in patients with schizophrenia. Trop Biomed. 2012;29(1):151–159.
   Web of Science ®Google Scholar
• Cetinkaya Z, Yazar S, Gecici O, Namli MN. Anti-Toxoplasma gondii antibodies in patients with schizophrenia – preliminary findings in a Turkish sample. Schizophr Bull. 2007;33(3):789–791.
   PubMed Web of Science ®Google Scholar
• Hamidinejat H, Ghorbanpoor M, Hosseini H, et al. Toxoplasma gondii infection in first-episode and inpatient individuals with schizophrenia. Int J Infect Dis. 2010;14(11):e978–e981.
   Web of Science ®Google Scholar
• Alvarado-Esquivel C, Urbina-álvarez JD, Estrada-Martínez S, et al. Toxoplasma gondii infection and schizophrenia: a case control study in a low Toxoplasma seroprevalence Mexican population. Parasitol Int. 2011;60(2):151–155.
   Web of Science ®Google Scholar
• Zhu S, Guo MF, Feng QC, Fan JM, Zhang LX. Epidemiological evidences from China assume that psychiatric-related diseases may be associated with Toxoplasma gondii infection. Neuro Endocrinol Lett. 2007;28(2):115–120.
   Web of Science ®Google Scholar
• Arias I, Sorlozano A, Villegas E, et al. Infectious agents associated with schizophrenia: a meta-analysis. Schizophr Res. 2012;136(1–3):128–136.
   PubMed Web of Science ®Google Scholar
• Dupont CD, Christian DA, Hunter CA. Immune response and immunopathology during toxoplasmosis. Semin Immunopathol. 2012;34(6):793–813.
   PubMed Web of Science ®Google Scholar
• Maksimov P, Zerweck J, Maksimov A, et al. Peptide microarray analysis of in silico-predicted epitopes for serological diagnosis of Toxoplasma gondii infection in humans. Clin Vac Immunol. 2012;19:865–874.
   PubMed Web of Science ®Google Scholar
• Flegr J. Schizophrenia and Toxoplasma gondii: an underevaluated association. Expert Rev Anti Infect Ther. 2015;31:1–4.
   Google Scholar
• Pearce BD, Kruszon-Moran D, Jones JL. The relationship between Toxoplasma gondii infection and mood disorders in the third National Health and Nutrition Survey. The relationship between Toxoplasma gondii infection and mood disorders in the third National Health and Nutrition Survey. Biol Psychiat. 2012;72(4):290–295.
   Web of Science ®Google Scholar
• Hamdani N, Daban-Huard C, Lajnef M, et al. Relationship between Toxoplasma gondii infection and bipolar disorder in a French sample. J Affect Disord. 2013;148(2–3):444–448.
   Web of Science ®Google Scholar
• Dickerson F, Stallings C, Origoni A, et al. Antibodies to Toxoplasma gondii in individuals with mania. Bipolar Disord. 2014;16(2):129–136.
   Web of Science ®Google Scholar
• Gale SD, Brown BL, Berrett A, Erickson LD, Hedges DW. Association between latent toxoplasmosis and major depression, generalised anxiety disorder and panic disorder in human adults. Folia Parasitol (Praha). 2014;61(4):285–292.
   PubMed Web of Science ®Google Scholar
• Hinze-Selch, D, Däubener W, Erdag E, Wilms S. The diagnosis of a personality disorder increases the likelihood for seropositivity to Toxoplasma gondii in psychiatric patients. Folia Parasitol (Praha). 2010;57:129–135.
   PubMed Web of Science ®Google Scholar
• Jones-Brando L, Torrey EF, Yolken R. Drugs used in the treatment of schizophrenia and bipolar disorder inhibit the replication of Toxoplasma gondii. Schizophr Res. 2003;62(3):237–244.
   PubMed Web of Science ®Google Scholar
• Fond G, Macgregor A, Tamouza R, et al. Comparative analysis of anti-toxoplasmic activity of antipsychotic drugs and valproate. Eur Arch Psychiatry Clin Neurosci. 2014;264(2):179–183.
   Web of Science ®Google Scholar
• Wang HL, Xiang YT, Li QY, et al. The effect of artemether on psychotic symptoms and cognitive impairment in first-episode, antipsychotic drug-naive persons with schizophrenia seropositive to Toxoplasma gondii. J Psychiatr Res. 2014;53:119–124.
   Web of Science ®Google Scholar
• Dickerson FB, Stallings CR, Boronow JJ, Origoni AE, Yolken RH. A double-blind trial of adjunctive azithromycin in individuals with schizophrenia who are seropositive for Toxoplasma gondii. Schizophr Res. 2009;112(1–3):198–199.
   Web of Science ®Google Scholar
• Stock AK, Heintschel von Heinegg E, Köhling HL, Beste C. Latent Toxoplasma gondii infection leads to improved action control. Brain Behav Immun. 2014;37:103–108.
   Web of Science ®Google Scholar
• Pearce BD, Hubbard S, Rivera HN, et al. Toxoplasma gondii exposure affects neural processing speed as measured by acoustic startle latency in schizophrenia and controls. Schizophr Res. 2013;150(1):258–261.
   Web of Science ®Google Scholar
• Priplatova L, Sebankova B, Flegr J. Contrasting effect of prepulse signals on performance of toxoplasma-infected and toxoplasma-free subjects in an acoustic reaction times test. PLoS One. 2014;9(11):e112771.
   Web of Science ®Google Scholar
• Zhang Y, Träskman-Bendz L, Janelidze S, et al. Toxoplasma gondii immunoglobulin G antibodies and nonfatal suicidal self-directed violence. J Clin Psychiatry. 2012;73(8):1069–1076.
   PubMed Web of Science ®Google Scholar
• Pedersen MG, Mortensen PB, Norgaard-Pedersen B, Postolache TT. Toxoplasma gondii infection and self-directed violence in mothers. Arch Gen Psychiatry. 2012;69(11):1123–1130.
   Web of Science ®Google Scholar
• Alvarado-Esquivel C, Sánchez-Anguiano LF, Arnaud-Gil CA, et al. Toxoplasma gondii infection and suicide attempts: a case-control study in psychiatric outpatients. J Nerv Ment Dis. 2013;201(11):948–952.
   PubMed Web of Science ®Google Scholar
• Alvarado-Esquivel C, Alvarado-Esquivel D, Dubey JP. Prevalence of Toxoplasma gondii antibodies in domestic donkeys (Equus asinus) in Durango, Mexico slaughtered for human consumption. BMC Vet Res. 2015;11(1):6.
   Google Scholar
• Alvarado-Esquivel C, Pacheco-Vega SJ, Hernández-Tinoco J, et al. Lack of association between Toxoplasma gondii infection and occupational exposure to animals. Eur J Microbiol Immunol (Bp). 2014;4(4):184–192.
   Google Scholar
• Alvarado-Esquivel C, Pacheco-Vega S, Hernández-Tinoco J, et al. Toxoplasma gondii infection in interstate truck drivers: a case-control seroprevalence study. Parasit Vectors. 2015;8(1):77.
   Google Scholar
• Jones JL, Parise ME, Fiore AE. Neglected parasitic infections in the United States: toxoplasmosis. Am J Trop Med Hyg. 2014;90(5):794–799.
   PubMed Web of Science ®Google Scholar
• Ayral F, Artois J, Zilber AL, et al. The relationship between socioeconomic indices and potentially zoonotic pathogens carried by wild Norway rats: a survey in Rhône, France (2010–2012). Epidemiol Infect. 2015;143(3):586–599.
   Web of Science ®Google Scholar
• Xu P, Li X, Guo L, et al. Seroprevalence of Toxoplasma gondii infection in Liaoning cashmere goat from northeastern China. Parasite. 2014;21:22.
   Google Scholar
• Flegr J. How and why Toxoplasma makes us crazy. Trends Parasitol. 2013;29(4):156–163.
   PubMed Web of Science ®Google Scholar
• Flegr J. Influence of latent Toxoplasma infection on human personality, physiology and morphology: pros and cons of the Toxoplasma-human model in studying the manipulation hypothesis. J Exp Biol. 2013;216(Pt 1):127–133.
   Web of Science ®Google Scholar
• Dickerson F, Stallings C, Origoni A, et al. Antibodies to Toxoplasma gondii and cognitive functioning in schizophrenia, bipolar disorder, and nonpsychiatric controls. J Nerv Ment Dis. 2014;202(8):589–593.
   Web of Science ®Google Scholar
• Pearce BD, Kruszon-Moran D, Jones JL. The association of Toxoplasma gondii infection with neurocognitive deficits in a population-based analysis. Soc Psychiatry Psychiatr Epidemiol. 2014;49(6):1001–1010.
   PubMed Web of Science ®Google Scholar
• Gajewski PD, Falkenstein M, Hengstler JG, Golka K. Toxoplasma gondii impairs memory in infected seniors. Brain Behav Immun. 2014;36:193–199.
   Web of Science ®Google Scholar
• Beste C, Getzmann S, Gajewski PD, Golka K, Falkenstein M. Latent Toxoplasma gondii infection leads to deficits in goal-directed behavior in healthy elderly. Neurobiol Aging. 2014;35(5):1037–1044.
   Web of Science ®Google Scholar
• Gale SD, Brown BL, Erickson LD, Berrett A, Hedges DW. Association between latent toxoplasmosis and cognition in adults: a cross-sectional study. Parasitology. 2015;142(4):557–565.
   Web of Science ®Google Scholar
• Carter CJ. Toxoplasmosis and polygenic disease susceptibility genes: extensive Toxoplasma gondii host/pathogen interactome enrichment in nine psychiatric or neurological disorders. J Pathog. 2013;2013:965046.
   PubMedGoogle Scholar
• Notarangelo FM, Wilson EH, Horning KJ, et al. Evaluation of kynurenine pathway metabolism in Toxoplasma gondii-infected mice: implications for schizophrenia. Schizophr Res. 2014;152(1):261–267.
   Web of Science ®Google Scholar
• Henriquez SA, Brett R, Alexander J, Pratt J, Roberts CW. Neuropsychiatric disease and Toxoplasma gondii infection. Neuroimmunomodulation. 2009;16(2):122–133.
   PubMed Web of Science ®Google Scholar
• Xiao J, Li Y, Prandovszky E, et al. MicroRNA-132 dysregulation in Toxoplasma gondii infection has implications for dopamine signaling pathway. Neuroscience. 2014;268:128–138.
   PubMed Web of Science ®Google Scholar
• Jia B, Lu H, Liu Q, Yin J, Jiang N, Chen Q. Genome-wide comparative analysis revealed significant transcriptome changes in mice after Toxoplasma gondii infection. Parasit Vectors. 2013;6:161.
   Web of Science ®Google Scholar
• Bhadra R, Cobb DA, Weiss LM, Khan IA. Psychiatric disorders in toxoplasma seropositive patients – the CD8 connection. Schizophr Bull. 2013;39(3):485–489.
   Web of Science ®Google Scholar
• Yarovinsky F. Innate immunity to Toxoplasma gondii infection. Nat Rev Immunol. 2014;14(2):109–121.
   PubMed Web of Science ®Google Scholar
• Suzuki Y, Sa Q, Gehman M, Ochiai E. Interferon-gamma- and perforin-mediated immune responses for resistance against Toxoplasma gondii in the brain. Expert Rev Mol Med. 2011;13:e31.
   PubMed Web of Science ®Google Scholar
• Severance EG, Kannan G, Gressitt KL, et al. Anti-gluten immune response following Toxoplasma gondii infection in mice. PLoS One. 2012;7(11):e50991.
   Web of Science ®Google Scholar
• Cohen SB, Denkers EY. The gut mucosal immune response to Toxoplasma gondii. Parasite Immunol. 2015;37(3):108–117.
   Web of Science ®Google Scholar
• Severance EG, Yolken RH, Eaton WW. Autoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: more than a gut feeling. Schizophr Res. 2014. pii: S0920-964(14)00319-3.
   Web of Science ®Google Scholar
• Severance EG, Alaedini A, Yang S, et al. Gastrointestinal inflammation and associated immune activation in schizophrenia. Schizophr Res. 2012;138(1):48–53.
   Web of Science ®Google Scholar
• Severance EG, Gressitt KL, Yang S, et al. Seroreactive marker for inflammatory bowel disease and associations with antibodies to dietary proteins in bipolar disorder. Bipolar Disord. 2014;16(3):230–240.
   Web of Science ®Google Scholar
• Reeves GM, Mazaheri S, Snitker S, et al. A positive association between T. gondii seropositivity and obesity. Front Public Health. 2013;1:73.
   Google Scholar
• Flegr J, Príplatova L, Hampl R, Bicikovíá M, Ripova D, Mohr P. Difference of neuro- and immunomodulatory steroids and selected hormone and lipid concentrations between Toxoplasma-free and Toxoplasma-infected but not CMV-free and CMV-infected schizophrenia patients. Neuro Endocrinol Lett. 2014;35(1):20–27.
   Web of Science ®Google Scholar
• Portugal LR, Fernandes LR, Alvarez-Leite JI. Host cholesterol and inflammation as common key regulators of toxoplasmosis and artherosclerosis development. Expert Rev Anti Infect Ther. 2009;7(7):807–819.
   PubMedGoogle Scholar
• Harker KS, Ueno N, Wang T, Bonhomme C, Liu W, Lodoen MB. Toxoplasma gondii modulates the dynamics of human monocyte adhesion to vascular endothelium under fluidic shear stress. J Leukoc Biol. 2013;93(5):789–800.
   Web of Science ®Google Scholar
• Sirota P, Hadi E, Djaldetti M, Bessler H. Difference in inflammatory cytokine production by mononuclear cells from obese and non-obese schizophrenic patients. Acta Psychiatr Scand. 2015. doi: 10.1111/acps.12396.
   Web of Science ®Google Scholar
• Knolle-Veentjer S, Huth V, Ferstl R, Aldenhoff JB, Hinze-Selch D. Delay of gratification and executive performance in individuals with schizophrenia: putative role for eating behavior and body weight regulation. J Psychiatr Res. 2008;42(2):98–105.
   Web of Science ®Google Scholar
• Sutterland AL, Fond G, Kuin A, et al. Beyond the association. Toxoplasma gondii in schizophrenia, bipolar disorder, and addiction: systematic review and meta-analysis. Acta Psychiatr Scand. 2015;15. doi: 10.1111/acps.12423.
   Google Scholar
• Koch JM, Hinze-Selch D, Stingele K, et al. Changes in CREB phosphorylation and BDNF plasma levels during psychotherapy of depression. Psychother Psychosom. 2009;78(3):187–192.
   Web of Science ®Google Scholar
• Müller KU, Mennigen E, Ripke S, et al. Altered reward processing in adolescents with prenatal exposure to maternal cigarette smoking. JAMA Psychiatry. 2013;70(8):847–856.
   PubMed Web of Science ®Google Scholar
• Potthast N, Neuner F, Catani C. The contribution of emotional maltreatment to alcohol dependence in a treatment-seeking sample. Addict Behav. 2014;39(5):949–958.
   PubMed Web of Science ®Google Scholar